Related Experiment Video
Updated: Aug 16, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
A favipiravir-induced angioedema and urticaria in a COVID-19 patient
Figen Ergur Ozturk1, Ayperi Ozturk1, Hale Ates2
1Interventional Pulmonology Department, Health Sciences University Faculty of Medicine, 146990Atatürk Chest Diseases and Thoracic Surgery Training and Research Hospital, Ankara, Turkey.
Abstract:
Although favipiravir is a promising drug for coronavirus disease 2019, some adverse effects, including skin lesions, have been reported. A 56-year-old female who was prescribed favipiravir by a filiation team following a positive severe acute respiratory syndrome coronavirus 2 polymerase chain reaction test presented to our hospital. After examination, favipiravir and paracetamol were prescribed. She represented to the hospital with facial swelling and itchy rashes on her forearm. Angioedema and urticaria were diagnosed. Favipiravir was discontinued. Steroid and antihistaminic therapy were administered for angioedema. To our knowledge, this is the first reported case of favipiravir-induced angioedema and urticaria in Turkey.
More Related Videos
07:56Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis
Published on: May 5, 2023
09:07Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
Published on: January 20, 2017
Related Concept Videos
Myocarditis III: Medical Management
Allergic Drug Reactions
Allergic Reactions
Endocarditis II: Clinical Features of Infective Endocarditis
Pericarditis III: Medical Management
Myocarditis IV: Nursing Management